Press release
Embarc Advisors Ranks on 2025 Inc. 5000 List of Fastest-Growing Private Companies in America
San Francisco, CA - August 13, 2025 - Embarc Advisors [https://embarcadvisors.com/], an M&A and strategic finance advisory firm, is thrilled to announce its inclusion on the 2025 Inc. 5000 [https://www.inc.com/profile/tax-hack] list of the fastest-growing private companies in the United States. The recognition places Embarc among the most dynamic and trailblazing businesses across the country."When we founded Embarc Advisors, the mission was to redefine how corporate finance advisory is delivered, putting transparency, execution, and client alignment at the core," says Jay Jung [https://www.linkedin.com/in/embarc/], Founder & Managing Partner of Embarc Advisors. "Being named to the Inc. 5000 is not just a celebration of our growth, but of the trust our clients place in us every day to help them achieve transformative outcomes."
The firm's continued momentum underscores its distinctive approach to corporate finance and M&A advisory, as well as its commitment to long-term client partnerships.
Beyond its national ranking, Embarc has earned impressive distinctions across multiple sectoral categories. The firm continues to expand its influence as a trusted partner to startups and middle-market companies navigating capital raises, strategic initiatives, and transformative transactions.
"Earning this spot on the Inc. 5000 reflects the exceptional commitment and expertise of our people," says Doug Nafziger, Chief Operating Officer of Embarc Advisors. "At Embarc Advisors, our clients entrust us with some of their most important financial decisions, and this recognition affirms that they deeply value the quality, precision, and integrity of our work every day."
This year's Inc. 5000 recognition adds to a growing list of honors for Embarc Advisors, including:
*
Inc. Magazine's Fastest Growing Companies - Pacific Region (Ranked #21 in 2024)
*
Axial's Top Investment Banking Firms (Ranked #7 in 2024)
*
Axial's Top 25 Lower Middle Market Investment Banks | Q1 (Ranked 23)
Since its founding in 2020, Embarc Advisors has advised on numerous high-impact transactions, from early-stage funding to $100M+ growth equity raises and M&A deals, while also acting as an embedded strategic CFO team for many high-growth clients.
To learn more about Embarc Advisors, visit https://www.embarcadvisors.com.
Media inquiries:
Alexia McKay
alexia.mckay@otterpr.com [mailto:alexia.mckay@otterpr.com]
About Embarc Advisors
Founded by former Goldman Sachs investment banker and McKinsey & Co. consultant Jay Jung, Embarc Advisors is a M&A and strategic finance advisory firm that supports startups, SMBs, and middle-market firms. Backed by a team with decades of combined experience across investment banking, private equity, consulting, and FP&A, Embarc is trusted by companies looking to scale smartly and capitalize on strategic opportunities in an increasingly complex business landscape.
Media Contact
Company Name: Otter PR
Contact Person: Alexia McKay
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=embarc-advisors-ranks-on-2025-inc-5000-list-of-fastestgrowing-private-companies-in-america]
State: Florida
Country: United States
Website: http://OtterPR.com
Legal Disclaimer: Information contained on this page is provided by an independent third-party content provider. ABNewswire makes no warranties or responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you are affiliated with this article or have any complaints or copyright issues related to this article and would like it to be removed, please contact retract@swscontact.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Embarc Advisors Ranks on 2025 Inc. 5000 List of Fastest-Growing Private Companies in America here
News-ID: 4144593 • Views: …
More Releases from ABNewswire
Alzheimer's Disease Market in the 7MM is projected to reach USD 34 Billion by 20 …
Key players operating in the Alzheimer's disease market include Eisai, Biogen, Changchun Huayang High-tech Co. Ltd., Hoffmann-La Roche, vTv Therapeutics, AZTherapies, Cerecin, Neurotrope, Lyndra, AC Immune, INmune Bio, Cassava Sciences, EIP Pharma, Neuraly, AB Science, Cortexyme, Anavex Life Sciences, Athira Pharma, Time Therapeutics, Prilenia Therapeutics, Denali Therapeutics Inc., Stemedica Cell Technologies, Inc., along with several other emerging and established companies.
The Alzheimer's disease market was valued at approximately USD 3,610 million…
Glaucoma Market Forecast 2034: USD 4,073 Million Market Size, 30+ Companies, and …
Major Glaucoma players include Allergan (AbbVie), Sun Pharma Advanced Research Company Limited, Santen Pharmaceutical Co., Ltd., Alcon, D. Western Therapeutics Institute (DWTI), Kowa Ltd., Senju Pharmaceuticals, Otsuka Pharmaceuticals, Bausch and Lomb, Novartis, Merck & Co., Aerie Pharmaceuticals, Nicox Ophthalmics, Sylentis, Envisia Therapeutics, Ocuphire Pharma, TearClear, Peregrine Ophthalmic, and others.
The Glaucoma Market across the seven major markets (7MM) - the United States, EU4 (Germany, France, Italy, and Spain), the United Kingdom,…
Graves' Disease Market Size in the 7MM was ~USD 4,400 million in 2023 and is exp …
DelveInsight's "Graves' Disease Market Insights, Epidemiology, and Market Forecast-2034 report offers an in-depth understanding of the Graves' Disease, historical and forecasted epidemiology as well as the Graves' Disease market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan.
Explore Graves' Disease Market Trends, treatment landscapes, and emerging therapies shaping the future. Download sample report @ [https://www.delveinsight.com/sample-request/graves-disease-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=ypr]
Key Takeaways from the Graves' Disease Market Report
* In December…
Myelofibrosis Market in the 7MM is projected to grow at a CAGR of 9% by 2034, es …
DelveInsight's 'Myelofibrosis Market Insight, Epidemiology, and Market Forecast-2034' report delivers an in-depth understanding of myelofibrosis, historical and forecasted epidemiology as well as the myelofibrosis therapeutics market trends in the United States, EU4 (Germany, France, Italy, and Spain) and the United Kingdom, and Japan.
Discover more about the Myelofibrosis Market in detail @ Myelofibrosis Treatment Market Report @ https://www.delveinsight.com/sample-request/myelofibrosis-mf-market [https://www.delveinsight.com/sample-request/myelofibrosis-mf-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=ypr]
Key Takeaways from the Myelofibrosis Market Report
* On January 09, 2026, Swedish Orphan…
More Releases for Embarc
Read My MRI Launches Read My Labs to Provide Clear, Patient-Friendly Lab Result …
Read My MRI has launched Read My Labs, a new AI-powered service that explains blood test results in clear, everyday language. The service is designed to help patients understand their lab reports and support more informed conversations with their healthcare providers.
Read My MRI, a healthcare technology company focused on patient-friendly medical report explanations, today announced the launch of Read My Labs, a new service that provides clear, accessible summaries of…
Global Bronchiectasis Drugs Market Set to Soar Amid Rising Respiratory Disease B …
The Global Bronchiectasis Drugs Market is expected to reach at a Significant CAGR during the forecast period 2024-2031.
The Bronchiectasis Drugs Market, as analyzed by DataM Intelligence, offers a comprehensive industry overview backed by in-depth insights, historical trends, and key statistics. The report dives deep into market dynamics and competitive strategies, profiling major players along with their product portfolios, pricing models, financial performance, growth initiatives, and regional presence.
Unlock exclusive insights with…
Embarc Advisors Named Among Top 50 Lower Middle Market Technology Investors & M& …
Embarc Advisors Join Axial's Prestigious 2025 List
Los Angeles, California - April 2, 2025 - Embarc Advisors [https://embarcadvisors.com/], a corporate finance advisory firm, has been recognized as one of the Top 50 Lower Middle Market Technology Investors & M&A Advisors for 2025 by Axial. [https://www.axial.net/forum/the-top-50-lower-middle-market-technology-investors-ma-advisors-2025/] This prestigious acknowledgment highlights Embarc's innovative approach to mergers and acquisitions (M&A) and its commitment to delivering superior client outcomes.
"We are incredibly proud to be recognized…
Bronchiectasis Drugs Market Size, Share, Growth Insights and Report 2024-2031 | …
DataM Intelligence has released a new research report on the Bronchiectasis Drugs market. The report provides a detailed analysis of current and emerging trends, offering insights into the market dynamics. It utilizes Porter's Five Forces model to assess key factors such as supplier and customer relationships, risks from various agents, competitive intensity, and opportunities for new entrants. The study also includes research data from various companies, analyzing factors like benefits,…
Embarc Advisors Celebrates Inclusion in the Inc. 5000 List of Nation's Fastest-G …
Embarc Advisors [https://embarcadvisors.com/], an M&A and strategic finance advisory firm renowned for its unique hourly billing model, proudly announces its inclusion in the prestigious Inc. 5000 list, ranking 477 among the nation's fastest-growing private companies. This is Embarc Advisors' first appearance on the esteemed list, highlighting its rapid growth and success in the business advisory sector.
Embarc Advisors has achieved notable milestones, ranking 24th in the San Francisco, Oakland, and Berkeley…
Embarc Advisors Serves As The Sole M&A Advisor To Vizzia Technologies On Its Sal …
Los Angeles, California - Embarc Advisors [https://embarcadvisors.com/], a disruptive and Axial top-rated [https://www.axial.net/forum/top-25-lower-middle-market-investment-banks-of-2023/?utm_campaign=MMR%20Newsletter&utm_medium=email&_hsmi=292018127&_hsenc=p2ANqtz-_gBZkA0dylui8vJ-NBVVZd1iaUK-W69B5T_2BKGRq9aUzv_3mx0FtqieTCkfvD2D7tQFw5m82dcJUC07F2_hDT1MkGcKPPazA4jObQO5SordvJx4U&utm_content=292018127&utm_source=hs_email] corporate finance advisory firm that focuses on supporting startups and middle-market firms, recently played a crucial role in guiding Vizzia Technologies through its sale to HID Global, a prominent maker of secure identity solutions. Vizzia Technologies specializes in using Internet of Things (IoT) technology to enhance healthcare services.
"We first encountered Embarc Advisors when they were advising a…
